I have enough context from the library and my medical knowledge to now craft high-quality 15-mark essay questions covering the full syllabus listed. Here are the questions:
Microbiology Internal Examination
15-Mark Essay Questions
Topics: Infective Syndromes of CNS, GI Tract & Hepatobiliary System
SECTION A: Central Nervous System Infections
Q1. Bacterial Meningitis
(MI 6.2 | 15 marks)
Describe the etiology, pathogenesis, and clinical features of bacterial meningitis. Discuss the laboratory diagnosis with emphasis on CSF analysis, and outline the principles of treatment and prevention.
Expected outline (15 marks):
- Etiology (3 marks): Neisseria meningitidis, Streptococcus pneumoniae, Listeria monocytogenes, H. influenzae type b; age-related causes
- Pathogenesis (3 marks): route of infection (nasopharynx → blood → meninges → subarachnoid space), BBB disruption, inflammatory cascade, cerebral edema
- Clinical features (2 marks): fever, nuchal rigidity, Kernig's sign, Brudzinski's sign, petechial rash (meningococcal), altered sensorium
- CSF analysis (4 marks): turbid appearance, raised pressure, neutrophilic pleocytosis, low glucose, raised protein; Gram stain, culture, India ink, latex agglutination
- Treatment & prevention (3 marks): empirical antibiotics (ceftriaxone ± dexamethasone), dexamethasone for adjunctive therapy, meningococcal/pneumococcal vaccines, chemoprophylaxis with rifampicin
Q2. Tetanus
(MI 5.1 | 15 marks)
Write an essay on tetanus. Describe the mechanism of action of tetanospasmin, clinical types, diagnosis, management, and preventive measures including immunization schedule.
Expected outline (15 marks):
- Etiology & ecology (2 marks): Clostridium tetani, spore-forming anaerobe, ubiquitous in soil
- Toxin mechanism (3 marks): tetanospasmin cleaves synaptobrevin → blocks inhibitory neurotransmitter release (GABA, glycine) at spinal interneurons → sustained muscle spasm
- Clinical types (2 marks): generalized (most common - trismus, risus sardonicus, opisthotonos), localized, cephalic, neonatal
- Diagnosis (1 mark): primarily clinical (spatula test); no reliable lab test
- Management (4 marks): wound debridement, human tetanus immunoglobulin (HTIG), metronidazole/penicillin, diazepam/muscle relaxants, ICU care, airway management
- Prevention (3 marks): active immunization - DPT schedule (6w, 10w, 14w + boosters), Td booster every 10 years, wound management protocol (clean vs. tetanus-prone wounds)
Q3. Viral Meningitis and Myelitis
(MI 6.3 | 15 marks)
Compare and contrast viral (aseptic) meningitis and bacterial meningitis with respect to etiology, pathogenesis, CSF findings, and management. Add a note on viral myelitis.
Expected outline (15 marks):
- Etiology of viral meningitis (2 marks): enteroviruses (most common), HSV-2, mumps, HIV, arboviruses
- Pathogenesis (2 marks): hematogenous spread, olfactory nerve route (HSV), meningeal inflammation without bacterial invasion
- CSF comparison table (4 marks):
| Feature | Bacterial | Viral |
|---|
| Appearance | Turbid | Clear |
| Cells | Neutrophils (>1000) | Lymphocytes (100-500) |
| Protein | Markedly raised | Mildly raised |
| Glucose | Low (<45 mg/dL) | Normal |
| Gram stain | Positive | Negative |
- Management of viral meningitis (3 marks): supportive care; acyclovir for HSV meningitis; antiretrovirals for HIV
- Viral myelitis (4 marks): causes (poliovirus, HSV, EBV, CMV, HTLV-1), anterior horn cell involvement (flaccid paralysis in polio), diagnosis (MRI spine, CSF), treatment (acyclovir/steroids), polio eradication and OPV/IPV immunization
Q4. Viral Encephalitis and Encephalopathy
(MI 6.2 | 15 marks)
Discuss the etiology, pathogenesis, clinical features, diagnosis, and management of viral encephalitis. Describe the specific features of Herpes Simplex Encephalitis and Japanese Encephalitis.
Expected outline (15 marks):
- Definition & etiology (2 marks): HSV-1 (most common sporadic), arboviruses (Japanese Encephalitis, West Nile), rabies, EBV, CMV
- Pathogenesis (2 marks): direct viral neuronal invasion vs. immune-mediated; temporal lobe tropism (HSV), thalamic involvement (JE)
- Clinical features (2 marks): fever, headache, altered consciousness, seizures, focal neurological deficits, behavioral change
- Diagnosis (4 marks): CSF (lymphocytic pleocytosis, normal glucose), PCR (HSV-1 DNA - gold standard), MRI brain (temporal lobe hemorrhagic lesions in HSV), EEG (PLEDS in HSV), serology (IgM capture ELISA for JE)
- HSV encephalitis specifics (2 marks): acyclovir 10 mg/kg IV q8h for 14-21 days; mortality >70% without treatment
- Japanese Encephalitis (2 marks): Culex mosquito vector, pig as amplifying host, MRI thalamic/basal ganglia lesions, SA 14-14-2 live attenuated vaccine
- Prognosis & supportive care (1 mark): ICU monitoring, anti-seizure drugs, ICP management
Q5. Parasitic Infections of the CNS
(MI 6.3 | 15 marks)
Discuss the epidemiology, pathogenesis, clinical features, diagnosis, and treatment of neurocysticercosis and cerebral malaria. Add a note on cerebral toxoplasmosis in immunocompromised patients.
Expected outline (15 marks):
- Neurocysticercosis (5 marks): Taenia solium larval stage, feco-oral transmission (human as dead-end host), cystic lesions in parenchyma/ventricles, presenting as new-onset seizures in endemic areas; CT/MRI (ring-enhancing lesions, calcified nodules), CSF eosinophilia, ELISA serology; treatment with albendazole + prednisolone; contraindication of albendazole in ocular/spinal NCC
- Cerebral malaria (5 marks): Plasmodium falciparum, sequestration of parasitized RBCs in cerebral microcirculation, endothelial activation, cytokine storm; presents as impaired consciousness, seizures, coma; diagnosis by thick/thin smear, RDT, PCR; management: IV artesunate (first-line), dexamethasone contraindicated, anti-seizure drugs, anti-hypoglycemic measures
- Cerebral toxoplasmosis (5 marks): Toxoplasma gondii reactivation in HIV/AIDS (CD4 <100), multiple ring-enhancing lesions in basal ganglia on CT/MRI, serum IgG positive; empirical treatment with sulfadiazine + pyrimethamine + leucovorin for 6 weeks; secondary prophylaxis continued till CD4 >200
Q6. Fungal Infections of the CNS
(MI 6.3 | 15 marks)
Describe the etiology, predisposing factors, pathogenesis, clinical features, diagnosis, and management of cryptococcal meningitis. Briefly mention other fungal infections of the CNS.
Expected outline (15 marks):
- Etiology (1 mark): Cryptococcus neoformans (var. grubii - HIV) and C. gattii (immunocompetent)
- Predisposing factors (2 marks): HIV/AIDS (CD4 <100), organ transplant, corticosteroid therapy, lymphoma
- Pathogenesis (2 marks): inhalation of desiccated yeast → pulmonary infection → hematogenous spread to CNS; polysaccharide capsule evades phagocytosis; melanin production inhibits oxidative killing
- Clinical features (2 marks): insidious onset, headache, fever, meningism (often mild), papilledema, altered mentation
- Diagnosis (4 marks): CSF - raised pressure, lymphocytic pleocytosis, low glucose, raised protein; India ink stain (budding encapsulated yeast, "halo" appearance); cryptococcal antigen (CrAg) - latex agglutination/LFA (high sensitivity); fungal culture on Sabouraud's agar (mucoid colonies); MRI brain
- Management (3 marks): Induction - liposomal amphotericin B + flucytosine for 2 weeks; Consolidation - fluconazole 400 mg/day for 8 weeks; Maintenance - fluconazole 200 mg/day; LP for raised ICP
- Other fungal CNS infections (1 mark): aspergillosis (neutropenic), mucormycosis (diabetic/immunocompromised), candidal meningitis (neonates/ICU)
SECTION B: Gastrointestinal Infective Syndromes
Q7. Food Poisoning
(MI 4.2 | 15 marks)
Classify food poisoning. Describe the etiology, toxin mechanisms, clinical features, diagnosis, and management of Staphylococcal and Clostridium perfringens food poisoning. Add a note on Botulism.
Expected outline (15 marks):
- Classification (2 marks): pre-formed toxin (Staph., C. botulinum, B. cereus emetic), infection-mediated toxin (C. perfringens, ETEC), invasive (Salmonella, Shigella, Campylobacter)
- Staphylococcal food poisoning (4 marks): S. aureus heat-stable enterotoxin (A-E); contaminated cream/meat/salads; short incubation (1-6 hrs); profuse vomiting ± diarrhea, no fever; self-limiting; diagnosis: toxin detection in food; treatment: rehydration
- C. perfringens food poisoning (3 marks): type A strains produce heat-labile enterotoxin; undercooked meat; incubation 8-24 hrs; watery diarrhea, mild cramps, no vomiting; self-limiting
- Botulism (4 marks): C. botulinum types A, B, E; heat-labile neurotoxin blocks acetylcholine release at NMJ; incubation 12-72 hrs; descending flaccid paralysis, bulbar palsy, dry mouth, diplopia; infantile botulism (honey); diagnosis: mouse bioassay, toxin in serum/stool; treatment: trivalent antitoxin (ABE), mechanical ventilation, wound debridement
- General management (2 marks): ORS/IV fluids, electrolyte replacement, antibiotics only for invasive types
Q8. Cholera
(MI 4.4 | 15 marks)
Describe the epidemiology, pathogenesis, clinical features, laboratory diagnosis, treatment, and prevention of Cholera. Explain the mechanism of action of Cholera toxin at the molecular level.
Expected outline (15 marks):
- Epidemiology (1 mark): Vibrio cholerae O1 (El Tor biotype) and O139; pandemic spread; contaminated water, feco-oral
- Pathogenesis & toxin mechanism (4 marks): ingestion → colonization of small intestine → CT production → CT B subunit binds GM1 ganglioside → CT A subunit enters cell → activates adenylyl cyclase via Gs protein → cAMP accumulates → CFTR channel activation → massive Cl⁻ and H₂O secretion → Na⁺ follows (Na⁺-dependent absorption blocked); net: massive isotonic fluid loss
- Clinical features (3 marks): "rice-water" stools, profuse vomiting, severe dehydration (sunken eyes, skin turgor loss, cold clammy extremities), "washerwoman's hands", painless diarrhea, hypovolemic shock; Cholera gravis (purging rate >1 L/hr)
- Lab diagnosis (2 marks): dark-field microscopy (shooting-star motility), hanging drop preparation, stool culture on TCBS agar (yellow colonies O1; blue-green O139), string test, Widal-like agglutination, PCR
- Treatment (3 marks): cornerstone = ORS (WHO formula) or Ringer's lactate IV; doxycycline single dose (adults) / azithromycin (children, pregnant); zinc supplementation in children
- Prevention (2 marks): safe water/sanitation (WASH), oral cholera vaccines (Shanchol, OCV - 2 dose), case isolation
Q9. Gastrointestinal Infections due to Enterobacteriaceae
(MI 4.3 | 15 marks)
Discuss the pathogenic mechanisms, clinical syndromes, and laboratory diagnosis of diarrheal diseases caused by pathogenic Escherichia coli. Compare and contrast the different pathotypes.
Expected outline (15 marks):
- Introduction (1 mark): E. coli is the most common cause of bacterial gastroenteritis worldwide
- ETEC (3 marks): LT + ST toxins, traveler's diarrhea, watery non-bloody diarrhea, self-limiting; LT similar to cholera toxin (cAMP); ST activates guanylyl cyclase (cGMP)
- EPEC (2 marks): attaching-effacing lesions on enterocytes (A/E lesions), type III secretion system, infant diarrhea in developing countries, watery diarrhea
- EHEC/STEC (O157:H7) (4 marks): Shiga toxin (Stx1, Stx2) → inhibits protein synthesis in colonic and renal endothelium; bloody diarrhea → hemolytic uremic syndrome (HUS = hemolytic anemia + thrombocytopenia + acute renal failure); diagnosis: sorbitol-MacConkey agar (colorless), Shiga toxin PCR; antibiotics CONTRAINDICATED (increase Stx release)
- EIEC (2 marks): invades colonic epithelium like Shigella; dysentery picture (bloody mucoid stools); Sereny test positive
- EAEC (1 mark): stacked brick biofilm, persistent diarrhea in HIV/children
- Lab diagnosis overview (2 marks): stool culture, serotyping, PCR multiplex panels; SMAC agar for O157:H7; HeLa cell adhesion assay for EPEC
Q10. Intestinal Protozoan Infections
(MI 4.4 | 15 marks)
Describe the life cycle, pathogenesis, clinical features, diagnosis, and treatment of Entamoeba histolytica infection. Discuss the differences between intestinal amoebiasis and amoebic liver abscess. Add a note on Giardia lamblia infection.
Expected outline (15 marks):
- Life cycle (2 marks): cyst (infective stage) → ingested → trophozoite in colon → flask-shaped ulcers → cyst in lumen → passed in stool; trophozoites invade portal vessels → liver abscess
- Pathogenesis (2 marks): contact-dependent cytolysis via amoebapores, galactose-inhibitable lectin for adhesion, cysteine proteinases degrade ECM and IgA
- Intestinal amoebiasis (3 marks): flask-shaped ulcers in cecum/ascending colon, bloody mucoid diarrhea (amoebic dysentery), tenesmus; stool microscopy (trophozoites with ingested RBCs - pathognomonic), culture, stool antigen ELISA, PCR
- Amoebic liver abscess (4 marks): right lobe, anchovy sauce pus (lysed hepatocytes + RBCs, no neutrophils - sterile unless secondarily infected), fever + right hypochondriac pain + tender hepatomegaly; USS (hypoechoic lesion), serum ELISA (>90% sensitive), raised ALP; treatment: metronidazole 800 mg TID × 10 days + diloxanide furoate (luminal cyst killer)
- Differentiation table (1 mark): intestinal - bloody diarrhea, serological test negative/low; ALA - no diarrhea, high serology, requires image-guided aspiration if no response
- Giardia lamblia (3 marks): trophozoite (pear-shaped, 2 nuclei, 4 pairs of flagella) and cyst; attaches to duodenum/jejunum (no invasion); malabsorption syndrome, fatty foul-smelling stool, bloating; diagnosis: trophozoites in stool/duodenal aspirate, stool antigen ELISA; treatment: metronidazole/tinidazole
Q11. Viruses Causing Hepatitis
(MI 4.7 | 15 marks)
Compare and contrast the five hepatotropic viruses (HAV, HBV, HCV, HDV, HEV) with respect to their virology, mode of transmission, serological markers, clinical course, and management. Describe the serological diagnosis of Hepatitis B in detail.
Expected outline (15 marks):
- Comparative table (4 marks):
| Feature | HAV | HBV | HCV | HDV | HEV |
|---|
| Family | Picornaviridae | Hepadnaviridae | Flaviviridae | Deltaviridae | Hepeviridae |
| Genome | +ssRNA | dsDNA | +ssRNA | -ssRNA | +ssRNA |
| Transmission | Feco-oral | Parenteral/sexual/vertical | Parenteral | Parenteral (needs HBV) | Feco-oral |
| Chronicity | No | Yes (5-10%) | Yes (70-85%) | Yes | No (except HEV in pregnancy) |
| Vaccine | Yes | Yes | No | HBV vaccine protects | Yes (China) |
- HBV serological markers in detail (6 marks):
- HBsAg: surface antigen, first to appear, marker of current infection; persists >6 months = chronic
- Anti-HBs: protective antibody, marker of recovery/vaccination
- HBeAg: active viral replication, high infectivity
- Anti-HBe: seroconversion, low replication
- HBcAg: not detected in serum (intracellular)
- Anti-HBc IgM: acute infection; IgG = past/chronic
- HBV DNA: most sensitive marker of replication; quantified for treatment monitoring
- Window period: HBsAg negative but anti-HBs not yet present; detected by anti-HBc IgM
- Management (3 marks): HAV/HEV - supportive; HBV - tenofovir/entecavir (oral), peginterferon; HCV - direct-acting antivirals (DAA) - sofosbuvir + velpatasvir (pangenotypic, 12 weeks, >95% SVR); HDV - peginterferon alpha or bulevirtide
- Prevention (2 marks): hepatitis B vaccination (0-1-6 month schedule), HBIG for perinatal exposure, universal precautions, safe water (HAV/HEV)
Q12. Parasitic Infections of the Hepatobiliary System
(MI 9.1 | 15 marks)
Describe the life cycle, pathogenesis, clinical features, diagnosis, and treatment of: (a) Hydatid disease of the liver, and (b) Hepatic fascioliasis. Add a note on Visceral Leishmaniasis (Kala-azar).
Expected outline (15 marks):
- Hydatid disease (6 marks): Echinococcus granulosus; dogs (definitive) → sheep/cattle/humans (intermediate); ingested eggs → oncosphere → liver (65%) → hydatid cyst (pericyst + ectocyst + germinal layer + brood capsules + scolices + daughter cysts + hydatid sand); presents as slowly enlarging RHC mass, urticaria if leakage, anaphylaxis if rupture; USS (WHO-IWGE classification, Gharbi classification), X-ray (calcified ring), CT/MRI, Casoni intradermal test (low sensitivity), serology (ELISA/IHA); management: PAIR (Puncture-Aspiration-Injection-Reaspiration) or surgery; albendazole 15 mg/kg/day for 1-3 months
- Hepatic fascioliasis (4 marks): Fasciola hepatica (sheep liver fluke); ingested metacercariae on aquatic plants → excyst in duodenum → migrate through liver parenchyma → bile ducts; acute phase (liver migration): fever, tender hepatomegaly, eosinophilia; chronic phase: biliary obstruction, cholangitis; diagnosis: stool microscopy (operculated eggs), serology (FAST-ELISA), USS (bile duct thickening); treatment: triclabendazole (drug of choice)
- Visceral Leishmaniasis (5 marks): Leishmania donovani; Phlebotomus sandfly vector; reticuloendothelial cell invasion (liver, spleen, bone marrow); prolonged fever, massive splenomegaly (Banti's syndrome picture), hepatomegaly, pancytopenia, hypergammaglobulinemia, darkening of skin (kala = black, azar = fever); diagnosis: splenic/bone marrow aspirate (amastigotes/LD bodies), rK39 antigen strip test (highly sensitive), DAT; treatment: liposomal amphotericin B (first-line in India), miltefosine (oral), sodium stibogluconate
SECTION C: Mixed / Applied Questions
Q13. Intestinal Helminthic Infections
(MI 4.4 | 15 marks)
Describe the life cycle, pathogenesis, clinical features, diagnosis, and treatment of Ascariasis. Discuss the clinical significance of tissue-invasive helminths with special reference to Strongyloides stercoralis in immunocompromised patients.
Expected outline (15 marks):
- Ascariasis (6 marks): Ascaris lumbricoides (largest intestinal nematode); ingested eggs → L2 → penetrate intestinal wall → portal circulation → liver → lungs (Löffler's syndrome: cough, eosinophilia, transient pulmonary infiltrates) → swallowed → intestine → adult worm; complications: intestinal obstruction, biliary/pancreatic ascariasis, malnutrition; diagnosis: stool microscopy (unfertilized or fertilized eggs), CBC (eosinophilia); treatment: albendazole 400 mg single dose or mebendazole
- Strongyloides stercoralis (5 marks): unique feature - autoinfection cycle; filariform larvae penetrate skin → lungs → intestine → rhabditiform larvae → free-living OR filariform (autoinfection); hyperinfection syndrome in immunocompromised (corticosteroids, HTLV-1, HIV): massive larval dissemination carrying gut bacteria → septicemia, meningitis, multiorgan failure; diagnosis: stool (Baermann technique), serology (ELISA), duodenal aspirate; treatment: ivermectin (first-line), albendazole
- Other tissue-invasive helminths (4 marks): Toxocara (visceral larva migrans - hepatomegaly, eosinophilia, ocular involvement), Trichinella spiralis (undercooked pork - periorbital edema, myositis, eosinophilia), filariasis (Wuchereria bancrofti - lymphedema, elephantiasis; diagnosis: nocturnal blood smear/ICT; treatment: DEC), tissue tapeworms (cysticercosis vs. coenurosis)
Q14. Viral Gastroenteritis
(MI 4.2 | 15 marks)
Describe the etiological agents causing viral gastroenteritis. Discuss in detail the virology, pathogenesis, clinical features, diagnosis, and prevention of Rotavirus gastroenteritis. Add a note on Norovirus and Hepatitis E virus as causes of waterborne outbreaks.
Expected outline (15 marks):
- Etiological agents (2 marks): Rotavirus (most common in children <5), Norovirus (most common in adults/outbreaks), Adenovirus types 40/41, Astrovirus, Sapovirus
- Rotavirus - virology (2 marks): double-shelled dsRNA virus (Reoviridae), 11 segments, VP4 (P antigen) and VP7 (G antigen) determine serotype; 6 groups (A-F), Group A causes 90% of human infections
- Pathogenesis (2 marks): infects mature villous enterocytes → NSP4 (non-structural protein - acts as viral enterotoxin → intracellular Ca²⁺ elevation → Cl⁻ secretion) + villous destruction → malabsorption + secretory diarrhea
- Clinical features (2 marks): 1-3 day incubation, vomiting (prominent) followed by watery diarrhea 5-10 days, fever; severe dehydration in infants; winter seasonality
- Diagnosis (2 marks): stool ELISA for rotavirus antigen (rapid, sensitive), electron microscopy ("wheel-like" morphology - rota = wheel in Latin), RT-PCR for G/P typing
- Prevention (2 marks): Rotarix (RV1, 2 oral doses) and RotaTeq (RV5, 3 oral doses) - both live attenuated oral vaccines; included in national immunization programs; hand hygiene, safe water
- Norovirus (2 marks): Caliciviridae, +ssRNA; capsid protein VP1 (GII.4 dominant genotype); explosive projectile vomiting + watery diarrhea; cruise ship/school outbreaks; acid-stable, chlorine-resistant; no approved vaccine yet; diagnosis: RT-PCR, ELISA
- HEV as waterborne pathogen (1 mark): feco-oral, epidemics from contaminated water, especially dangerous in pregnancy (30% mortality in 3rd trimester), genotype 1 in South Asia
Q15. Miscellaneous Bacterial GI Infections + Integrated CNS-GI Question
(MI 4.6 + MI 6.3 | 15 marks)
A 25-year-old male returning from a rural endemic area presents with 3 weeks of high-grade fever, splenomegaly, headache, and rose spots on the abdomen. His blood culture grows Gram-negative rods. Discuss the diagnosis, pathogenesis, complications, and management. Also describe the Widal test and its limitations.
Expected outline (15 marks):
- Diagnosis (1 mark): Enteric fever (Salmonella typhi)
- Pathogenesis (3 marks): ingestion of S. typhi → penetrate Peyer's patches → mesenteric lymph nodes → primary bacteremia → seeding of liver/spleen/bone marrow → secondary bacteremia → clinical illness; Vi antigen and O antigen as virulence factors; intracellular survival in macrophages
- Clinical stages (2 marks): Week 1 (step-ladder fever), Week 2 (rose spots, splenomegaly, bradycardia relative to fever), Week 3 (complications), Week 4 (convalescence)
- Complications (2 marks): intestinal perforation (most feared), hemorrhage, encephalopathy (typhoid encephalitis), hepatitis, myocarditis, DIC
- Lab diagnosis (3 marks): Blood culture (gold standard - positive in 80-90% Week 1), bone marrow culture (most sensitive), stool/urine culture (Week 3); Widal test: agglutination titers against O and H antigens; single titer >1:160 (O) suggestive; rise in paired titers (4-fold) diagnostic; limitations - cross-reactions with other Salmonella, prior vaccination, endemic area (background titers), low sensitivity in early disease, does not distinguish acute from past infection
- Management (3 marks): ceftriaxone 2g IV (first-line for complicated/severe); azithromycin (uncomplicated, oral); fluoroquinolones (cipro - increasing resistance in South Asia); dexamethasone for encephalopathy/shock; perforation requires surgical management
- Prevention (1 mark): Ty21a (oral live attenuated) and Vi polysaccharide (IM) vaccines; safe food/water; sanitation
Tips for Writing 15-Mark Essays
| Component | Marks |
|---|
| Introduction / Definition | 1-2 |
| Etiology / Classification | 1-2 |
| Pathogenesis / Mechanism | 2-3 |
| Clinical Features | 2 |
| Diagnosis (lab emphasis) | 3-4 |
| Treatment | 2-3 |
| Prevention | 1 |
- Always draw a diagram or table where relevant (CSF comparison, serological markers, life cycle) - examiners award marks for well-labeled diagrams
- Mention "gold standard" tests explicitly
- Always write drug doses and duration where known
- End each answer with a brief note on public health/prevention